Blog

It's been 6 months since COVID-19 was declared a pandemic. Without a vaccine, there is a probability of a second wave. How can we apply what we've learned so far to help us prepare for the future?

Hear a patient's perspective on the impact of COVID-19 on immunocompromised clinical trial participants and how industry may be able to help.

Scenario planning is not just comparing two detailed data sets. To be meaningful, it must explore possible outcomes based on a specific combination of events while balancing risks and costs. With so many variables, how do you inform the best strategy? Here is our ultimate guide to scenario planning clinical supply decisions.

The key to seamless reconciliation is ensuring drug accountability. See how a site-based approach can reduce close out timelines and improve data accuracy.

Transitioning from traditional data servers to the cloud can lead to improved RTSM quality and more enhanced data security. See how!

An RTSM has critical functions with direct patient impact. As trials grow in complexity, adopting modern tech is inevitable for companies hoping to keep up.

4G Clinical partnered with SCRS to host their first Site Advisory Group for RTSM/IRT systems, where sites and sponsors gathered to discuss, among many other topics, what sites want from their IRT/RTSM.

4G Clinical partnered with SCRS to host their first Site Advisory Group for RTSM/IRT systems, where sites and sponsors gathered to discuss, among many other topics, how sponsors can become more site-centric.

In the 4th Debunking Clinical Trial Myths video you'll hear from Joseph Kim from Eli Lilly and Company on the reason for strict enrollment criteria.